cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Abd. Kakhar Umar
Contact Email
abdulkaharumar@gmail.com
Phone
+6282216335184
Journal Mail Official
sciphar@etflin.com
Editorial Address
Sungai Manonda Street, Syukur Aisle No. 2, RT 004/ RW 001, Duyu Village, Tatanga District
Location
Kota palu,
Sulawesi tengah
INDONESIA
Sciences of Pharmacy
Published by ETFLIN
ISSN : 28307046     EISSN : 28307259     DOI : https://doi.org/10.58920/sciphar
Core Subject : Health, Science, Engineering,
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Health Professions Medicine & Pharmacology Public Health
Sciences of Pharmacy (SciPhar) is an international, peer-reviewed open-access journal of pharmacy. We offer a platform and place for researchers and intellectuals, especially the youth, to share their insights and works. Every year, we hold seminars/webinars under the ETFLIN Scientific Society to facilitate the exchange of information concerning pharmacist research progress. Publication on SciPhar is free of charge at any stage. Scope We are accepting articles related to drug development (preclinical and clinical drug development, drug delivery, and pharmaceutical formulation). Fundamental and clinical pharmacology (drug mechanisms, pharmacokinetics, pharmacodynamics, drug metabolism, and pharmacogenetics). Pharmaceuticals (gene-based, cell-based, protein-based therapy, other drug modalities, routes of administration, drug classes, drug nomenclature). Drug toxicity and safety (drug-drug interactions, adverse drug reactions, mechanisms of drug toxicity, pharmacovigilance). Pharmacoepidemiology, pharmacoeconomics, and pharmacy.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Pharmacology, Toxicology and Pharmaceutics (Lain-Lain)
Articles 18 Documents
 1   2 
Search results for , issue "Volume 4 Issue 4" : 18 Documents clear
Evaluation of Antimicrobial Properties of Passiflora foetida Root Extract Sourced from Rehabilitated Coal Mining Sites in East Kalimantan Utami, Indah Woro; Sapri, Sapri; Meray, Nishia Waya; As'ari, As'ari
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404434

Abstract

Utilizing cover crops like Passiflora foetida L. (rambusa) can mitigate significant environmental issues in post-coal mining terrain rehabilitation. Plants thriving in extreme environments are known for producing high levels of secondary metabolites with significant biochemical activity. This study sought to assess the antifungal and antibacterial effects of P. foetida root extracts derived from rehabilitated coal mine soil in East Kalimantan. The roots were macerated with solvents of differing polarity (ethanol, ethyl acetate, and n-hexane) for extracting specific fractions. Utilizing the Kirby-Bauer disc diffusion method, the antifungal efficacy was assessed against Candida albicans, Candida tropicalis, and Candida lipolytica at a 60% concentration. Conversely, the antibacterial efficacy was assessed against Shigella dysenteriae, Streptococcus mutans, and Cutibacterium acnes at a 10% concentration. The findings revealed that the fraction consisting of ethyl acetate demonstrated the most potent and extensive antibacterial efficacy. The ethanol extract and ethyl acetate fraction exhibited significant antifungal activity, particularly against C. tropicalis, with inhibitory zones that were similar to those of the positive control, fluconazole. The treatments exhibited significant differences, as confirmed by statistical analysis (ANOVA and Tukey's HSD test). Studies indicate that that P. foetida roots, particularly those from harsh settings, are a significant source of antimicrobial chemicals, with the semi-polar ethyl acetate fraction being the most promising for further development as a natural antibacterial and antifungal agent.
Effectiveness of Apigenin–Banana Stem (Musa paradisiaca) Combination Gel on Incised Wound Healing Stiani, Sofi Nurmay; Selviani, Astri; Chairani, Farahdina; Yusransyah, Yusransyah; Udin, Baha
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Wound healing is a complex biological process involving inflammation, proliferation, and tissue remodeling. Delayed healing increases the risk of infection and other complications. Ambon banana stem (Musa acuminata) contains flavonoids, polyphenols, and tannins that support tissue regeneration, while apigenin exhibits anti-inflammatory and pro-regenerative activities. The combination of these two agents is expected to enhance wound repair. This study aimed to evaluate the effectiveness of a gel containing Ambon banana stem powder and apigenin in promoting wound healing in Sprague Dawley rats. A linear incision wound (1.5 cm × 2 mm) was created on the dorsal skin of anesthetized rats. Twenty-four male Sprague Dawley rats were divided into six groups (n = 4): untreated control (F0), negative control (gel base), positive control (Bioplacenton®), and three test formulations (F1: 5% banana stem + 10% apigenin; F2: 7.5% + 7.5%; F3: 10% + 5%). Wound length was measured daily for eight days using a digital caliper, and the percentage of wound closure was calculated. All combination gels significantly accelerated wound contraction compared with the negative control (p < 0.001). Formula F3 demonstrated the fastest healing, achieving complete closure on day 5 (1.50 ± 0.00 cm to 0.00 ± 0.00 cm), whereas the positive control reached 87.8 ± 0.15% closure by day 8. No significant differences were observed among the three test formulations. The accelerated healing is attributed to the synergistic effects of banana stem phytochemicals and apigenin. Overall, the combination gel effectively promotes wound healing and shows potential as a natural-based topical therapeutic.
Comparative Glycemic Effectiveness of Long- and Rapid-Acting Insulin in Patients with Type 2 Diabetes Mellitus Sutrisno, Entris; Kaniawati, Marita; Maharani, Ilmi Intan; Sodik, Jajang Japar
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404502

Abstract

Insulin therapy is essential for managing type 2 diabetes mellitus (T2DM), particularly in patients who fail to achieve glycemic targets with oral antidiabetic agents. Long-acting insulin is primarily used to control basal glucose levels, while rapid-acting insulin targets postprandial hyperglycemia. However, comparative real-world evidence regarding their effectiveness on glycated hemoglobin (HbA1c) and fasting blood glucose (FBG) remains limited. This study aimed to evaluate and compare the effectiveness of long-acting and rapid-acting insulin in improving HbA1c and FBG levels among patients with T2DM. A retrospective before–and–after observational study was conducted involving 122 T2DM patients treated at the outpatient unit of Majalaya Regional General Hospital between January and December 2024. Patients received either long-acting insulin (e.g., insulin glargine) or rapid-acting insulin (e.g., insulin lispro and insulin aspart) as monotherapy. Changes in HbA1c and FBG before and after therapy were analyzed using paired t-tests or Wilcoxon signed-rank tests. Clinical effectiveness was defined according to American Diabetes Association criteria as a reduction of ≥1% in HbA1c or ≥30 mg/dL in FBG. Insulin therapy significantly reduced HbA1c (−7.77 ± 3.09, p < 0.001) and FBG levels (Z = −5.53, p < 0.001). Based on ADA criteria, 90.3% of patients achieved an effective reduction in HbA1c, while 43.5% achieved an effective reduction in FBG. Insulin lispro and insulin glargine showed the highest HbA1c-based effectiveness (100%), whereas FBG-based effectiveness varied across formulations. Insulin therapy significantly improves long-term and short-term glycemic control in T2DM patients, with insulin lispro and insulin glargine demonstrating the most consistent effectiveness.
Liposomal Gel of Centella asiatica: Antioxidant Activity and Release Profile Indriaty, Sulistiorini; Firmansyah, Deni; Utami, Mima Eliestya; Karlina, Nina; Suharyani, Ine; Haidar, Hilal; Safitri, Amanda; Setiawati, Elis
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404437

Abstract

Centella asiatica (L.) Urban contains flavonoids and triterpenoids with strong antioxidant activity; however, its topical bioavailability is limited by poor solubility. This study aimed to formulate and evaluate liposomal gel systems containing a 70% ethanol extract of C. asiatica to enhance dermal penetration while preserving antioxidant activity. The extract was incorporated into liposomes using a lecithin–cholesterol ratio of 9:1 and formulated into gels at concentrations of 0.3% (FG1) and 0.5% (FG2). Physicochemical characterization showed mean particle sizes of 119.8 ± 7.21 nm (FG1) and 101.3 ± 6.55 nm (FG2), with polydispersity index values of 0.410 and 0.306, respectively, indicating acceptable vesicle homogeneity across three independent replicates (n = 3). The formulations were physically stable for two weeks at 4 °C but exhibited instability at elevated temperatures. Antioxidant activity evaluated using the DPPH assay yielded IC₅₀ values of 13.87 ± 0.02 µg/mL for FG1 and 13.97 ± 0.06 µg/mL for FG2, which were not significantly different (p > 0.05) from vitamin C (9.16 ± 0.06 µg/mL), indicating preservation of radical-scavenging capacity. In vitro permeation studies using Franz diffusion cells demonstrated cumulative quercetin penetration of 280.86 ± 1.12 µg/cm² for FG1 and 314.40 ± 0.93 µg/cm² for FG2 over 4 h, with FG2 showing significantly higher flux (p < 0.05). Release kinetics followed a zero-order model (R² = 0.9881–0.9914), suggesting controlled release behavior. Overall, liposomal gel formulations show potential for improving topical delivery of C. asiatica without overstating long-term stability or therapeutic superiority.
Development and Evaluation of Microcapsules Containing Combined Extracts of Bay, Cherry, and Green Betel Leaves as Natural Antioxidants Pratama, Reza; Budiana, Wempi; Zaelani, Diki; Asnawi, Aiyi
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404493

Abstract

Bay leaf (Syzygium polyanthum), cherry leaf (Muntingia calabura), and green betel leaf (Piper betle) contain phenolic and flavonoid compounds with antioxidant potential, but their utilization is limited by physicochemical instability. This study aimed to develop microcapsules containing a combined extract of these three leaves and to evaluate their physicochemical properties and in vitro antioxidant activity as an initial formulation feasibility study. Each extract was prepared by maceration using 96% ethanol, yielding 11.42–15.86%, and combined in a 1:1:1 (w/w/w) ratio prior to microencapsulation. Microcapsules were produced using a fluidized bed dryer with lactose as the core material and polyvinyl alcohol (PVA) as the coating polymer. Physicochemical characterization included moisture content, flow rate, angle of repose, compressibility index, dissolution time, particle size, and surface morphology. Antioxidant activity was assessed using DPPH and CUPRAC assays, with IC₅₀ values calculated from triplicate measurements. The coating process increased mean particle size from 636.2 µm to 728.0 µm and prolonged dissolution time from 2.14 to 3.55 minutes, indicating coating layer formation. Among the individual extracts, cherry leaf extract showed the strongest antioxidant activity. The microcapsules exhibited antioxidant activity within the same order of magnitude as the combined extract under initial, non-stressed testing conditions. These results demonstrate the feasibility of formulating combined plant extracts into microcapsules with acceptable physical properties, while further stability and comparative studies are required to support antioxidant preservation and potential applications.
Effect of Deferiprone on Hepatic Expression of Hamp, Ftl, and Tfr1 Genes in an Iron-Overloaded Rat (Rattus norvegicus) Model Salsabila, Nadhila Hasna; Kuntana, Yasmi Purnamasari; Arrizqiyani, Tanendri; Safitri, Ratu
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404387

Abstract

Iron overload is linked to progressive impairment of organ function, with the liver being the primary site of deposition due to the lack of a physiological route for iron elimination. The maintenance of systemic iron balance depends on key regulatory proteins, including hepcidin (Hamp gene), ferritin light chain (Ftl gene), and transferrin receptor 1 (Tfr1 gene). This study tested the hypothesis that Deferiprone (DFP), an oral iron chelator, modulates the hepatic expression of Hamp, Ftl, and Tfr1 genes in an iron-overloaded rat model. Eighteen male Wistar rats (150-200 g) were randomly assigned into three groups: Normal (N), Negative Control (NC; induced with Iron Dextran), and Treatment (T; Iron Dextran + DFP). Iron overload was induced via intravenous injection of Iron Dextran (120 mg/kg BW) over 15 days at 3-day intervals, while DFP was administered orally (100 mg/kg BW) in three divided doses for 28 consecutive days. Gene expression was assessed using RT-PCR, and relative quantification was performed using the Livak method. The iron-overloaded rats showed marked upregulation of Hamp and Ftl and downregulation of Tfr1. Administration of DFP significantly reversed these alterations, decreasing Hamp and Ftl levels while restoring Tfr1 expression to levels comparable to normal controls. These results highlight the potential role of DFP in modulating hepatic iron-regulatory genes under iron overload conditions. 
Evaluation of Quality of Life in Breast Cancer Patients: A Cross-Sectional Comparative Study between Targeted Therapy and Conventional Chemotherapy Pratama, Kharisma Jayak; Luthfiyanti, Niken
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404453

Abstract

Breast cancer is one of the most common cancers worldwide, with treatment often involving conventional therapies such as chemotherapy. Although effective, chemotherapy is often accompanied by significant side effects and reduces patients' quality of life. Targeted therapy, which targets specific molecular mechanisms in cancer cells, offers the potential to address these issues with higher efficacy and fewer side effects. This study aims to compare the quality of life of breast cancer patients receiving targeted therapy with chemotherapy. The study design used a comparative cross-sectional design involving 60 patients (30 receiving targeted therapy, 30 receiving chemotherapy) selected via consecutive sampling at RSUD Moewardi in Surakarta (January–June 2025). Data were collected using the validated Indonesian version of the EORTC QLQ-C30 questionnaire. Statistical analysis included parametric t-tests and non-parametric Mann-Whitney U tests. The study results showed that the targeted therapy group had better role functioning (p = 0.047.95% CI=0.044-0.053) and significantly lower pain (p= 0.001.95% CI=0.000-0.002) and nausea (p = 0.019.95% CI=0.016-0.021) symptoms compared to chemotherapy. Global health status did not differ significantly (p= 0.545.95% CI=0.536-0.556). Age (p = 0.012.95% CI=0.08-0.012) and stadium (p = 0.001.95% CI=0.001-0.003) significantly influenced global QoL. Targeted therapy provided advantages in functional aspects and specific symptoms, although not in global QoL. A key study limitation is its cross-sectional design, which prevents the establishment of causal relationships between the type of therapy and quality of life outcomes.
Analysis of Antibiotic Therapy Accuracy and Drug Interaction in Pneumonia Inpatients at The Islamic Hospital Jakarta Cempaka Putih Khairani, Sondang; Manninda, Reise; Ariani, Lusiana; Iskandar, Benni; Hidayati, Nabila Nur
Sciences of Pharmacy Volume 4 Issue 4
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0404456

Abstract

Polypharmacy may increase the risk of drug interactions affecting toxicity and therapeutic efficacy in pneumonia patients. This study aimed to analyse evaluation of pneumonia management, polypharmacy, relationship between polypharmacy and occurrence of drug-drug interactions, and relationship between drug-drug interactions and length of hospital stay of pneumonia patients. The study design used a quantitative descriptive approach with cross-sectional and retrospective data collection and a total sample of 113 samples that met the criteria. Analyses were performed using Spearman's rho correlation test to assess the association of polypharmacy with drug interactions, and the association of drug interactions with length of hospital stay. Medication accuracy was measured using PDPI (The Indonesian Lung Doctors Assosiaciation) guidelines, drug interactions using drugs.com and/or Medscape.com. Results showed 59.29% of patients were female, with the majority aged over 65 (55.65%). Most patients (91.15%) paid with BPJS, 62.61% were hospitalised for 1-5 days and 81.74% had comorbidities. Treatment accuracy in this study was 49.56%. 106 drug interactions were identified in a total of 226 cases. 66% of the interactions were pharmacodynamic with moderate severity (79%), such as the interaction between combivent and ondansetron. Mild pharmacokinetic interactions were common, especially between ranitidine and paracetamol (22 cases). There is a correlation between polypharmacy and drug interactions with a p-value 0.000 and there is a correlation between the number of drug interactions and length of hospitalisation with p-value 0.000. Conclusion of this study is polypharmacy increases the risk of drug interactions and affects the length of hospital stay in pneumonia patients.

Page 2 of 2 | Total Record : 18

 1   2 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue Volume 5 Issue 1 Volume 4 Issue 4 Volume 4 Issue 3 Volume 4 Issue 2 Volume 4 Issue 1 Volume 3 Issue 4 Volume 3 Issue 3 Volume 3 Issue 2 Volume 3 Issue 1 Volume 2 Issue 4 Volume 2 Issue 3 Volume 2 Issue 2 Volume 2 Issue 1 Volume 1 More Issue